Kawakami, J., & Morales, A. (2013). Clinical significance of suboptimal hormonal levels in men with prostate cancer treated with LHRH agonists. Canadian Urological Association Journal, 7(3-4), e226–30. https://doi.org/10.5489/cuaj.540